Objective: Monitor glycemic control following changes in antidiabetic medication Objective: Monitor glycemic control following changes in antidiabetic medication 56 type 2 diabetic patients treated with oral hypoglycemic agents for 4 weeks 56 type 2 diabetic patients treated with oral hypoglycemic agents for 4 weeks After 4 weeks, treatment discontinued in half of patients and monitored for 2 more weeks After 4 weeks, treatment discontinued in half of patients and monitored for 2 more weeks 1,5-AG, Glucose, A1C, and Fructosamine were measured 1,5-AG, Glucose, A1C, and Fructosamine were measured Clinical usefulness of serum 1,5-AG in monitoring glycemic control Yamanouchi T et al., The Lancet 1996
{}